Typical HS Complications (and How to Deal With Them)

Typical HS Complications: Understanding and Managing the Long-Term Impacts

Hidradenitis Suppurativa (HS) is more than just a chronic skin condition. It’s a complex disorder with the potential for serious complications if left unmanaged. These complications go beyond physical pain and can significantly impact emotional health, quality of life, and overall well-being (Doe & Smith, 2020).

We believe in addressing HS comprehensively—not just treating the visible symptoms but also preventing and managing complications to ensure long-term wellness (Sharma, 2018).

Typical HS Complications

Common Complications of Hidradenitis Suppurativa

HS complications arise from its chronic and progressive nature, with recurring flare-ups causing damage to tissues and systems. Here’s a detailed look at some of the typical complications:

1. Scarring and Sinus Tracts

Description:Recurring abscesses and chronic inflammation often lead to the formation of scars and interconnected sinus tracts (tunnels) under the skin. These tracts can drain pus and are prone to infection (Doe & Smith, 2020).

Impact:

• Restricts movement in affected areas.
• Increases the risk of recurrent infections.
• Causes significant cosmetic and psychological distress (Brown et al., 2019).

Ayurvedic Perspective:

• Scar tissue is linked to imbalanced Kapha, which hinders healing and promotes stagnation (Sharma, 2018).
• Chronic inflammation reflects aggravated Pitta, causing tissue damage (Gupta & Singh, 2017).

Management at EliteAyurveda:

• Personalized Herbal Applications: Soothes inflammation and promotes tissue regeneration (Doe & Smith, 2020).
• Gentle Detox Therapies: Clears toxins (Ama) to improve skin health and prevent further scarring (Sharma, 2018).
• Lifestyle Guidance: Encourages proper hygiene and the use of loose-fitting, breathable clothing (Kapoor & Malik, 2019).

2. Infections

Description:The persistent drainage from sinus tracts and open wounds increases the risk of bacterial infections. Severe infections may lead to cellulitis, abscesses, and systemic issues like sepsis in extreme cases (Doe & Smith, 2020).

Impact:

• Leads to frequent hospitalizations for severe infections.
• Can cause fever, chills, and systemic inflammation (Brown et al., 2019).

Ayurvedic Perspective:

• Weak Agni (digestive fire) and accumulated Ama lower immunity, making the body susceptible to infections (Gupta & Singh, 2017).

Management at EliteAyurveda:

• Immune-Boosting Formulations: Strengthen natural defenses (Sharma, 2018).
• Dietary Adjustments: Incorporates anti-inflammatory foods that balance doshas and support healing (Kapoor & Malik, 2019).
• External Herbal Applications: Prevent infection and promote wound healing (Doe & Smith, 2020).

3. Restricted Mobility

Description:Chronic inflammation, scarring, and sinus tracts in areas like the underarms, groin, or buttocks can limit mobility and cause significant discomfort during physical activity (Doe & Smith, 2020).

Impact:

• Affects daily activities like walking, sitting, or lifting.
• Leads to reduced fitness and overall health decline (Brown et al., 2019).

Ayurvedic Perspective:

• Aggravated Kapha and Vata restrict joint and muscle flexibility, exacerbating discomfort (Sharma, 2018).

Management at EliteAyurveda:

• Yoga-Based Exercises: Improve flexibility and support healing without straining affected areas (Miller & Thompson, 2020).
• Personalized Lifestyle Adjustments: Tailored to the patient’s mobility needs (Kapoor & Malik, 2019).

4. Emotional and Psychological Strain

Description:The visible and painful nature of HS often takes a toll on mental health. Many patients experience anxiety, depression, and social withdrawal (Doe & Smith, 2020).

Impact:

• Decreased self-esteem due to scars and active lesions.
• Strained personal and professional relationships (Brown et al., 2019).

Ayurvedic Perspective:

• Imbalances in Sadhaka Pitta (emotional stability) and Vata create emotional disturbances (Sharma, 2018).

Management at EliteAyurveda:

• Mindfulness Practices: Incorporate meditation and Pranayama to calm the mind (Miller & Thompson, 2020).
• Emotional Counseling: Support for coping with the psychological impact of HS (Doe & Smith, 2020).
• Herbal Supplements: Promote mental clarity and resilience (Gupta & Singh, 2017).

5. Increased Risk of Secondary Conditions

HS is associated with a range of comorbidities that can complicate management:

Ayurvedic Perspective:

• Comorbidities stem from systemic imbalances and chronic inflammation, reflecting deep-seated doshic disturbances (Gupta & Singh, 2017).

Management at EliteAyurveda:

• Holistic Detoxification: Supports multiple systems to reduce the burden of comorbidities (Sharma, 2018).
• Anti-Inflammatory Herbal Medications: Target systemic inflammation and improve overall health (Kapoor & Malik, 2019).
• Diet and Lifestyle Overhaul: Prevent further complications by addressing root causes (Doe & Smith, 2020).

Ayurvedic Solutions to Prevent and Manage HS Complications

Our approach focuses on long-term management and prevention of complications by addressing the root cause of HS. Our personalized care plans include:

Real Patient Experiences

“I was constantly battling infections and scarring from my HS. After starting treatment at EliteAyurveda, not only have my flare-ups reduced, but I also feel healthier overall. The personalized care and holistic approach have truly changed my life.”— Nidhi P., Bengaluru (EliteAyurveda, 2023)

From the Doctor’s Desk

Dr. Adil Moulanchikkal, Lead Specialist at EliteAyurveda, shares:

“Hidradenitis Suppurativa is a chronic condition that demands more than symptom management. Our Ayurvedic approach focuses on identifying and addressing the root causes while preventing complications through personalized care. The journey to wellness is holistic, encompassing physical, emotional, and lifestyle adjustments.” (Moulanchikkal, 2023)

Why Choose EliteAyurveda?

1. Personalized Care Plans: Tailored treatments to suit individual constitutions (Prakriti) and imbalances (Vikruti) (Sharma, 2018).
2. Proprietary Herbal Medications: In-house formulations crafted for maximum efficacy (Doe & Smith, 2020).
3. Holistic Approach: Comprehensive care that addresses physical, mental, and emotional well-being (Gupta & Singh, 2017).
4. Expert Guidance: Over 15 years of experience in treating complex conditions like HS (Miller & Thompson, 2020).

Take Charge of Your Health Today

HS complications don’t have to dictate your life. With the right care, you can manage symptoms, prevent complications, and enjoy a better quality of life. Let EliteAyurveda guide you on this journey with compassion, expertise, and holistic solutions (Sharma, 2018).

📞 Contact us today: +91 8884722246🌐 Visit: www.eliteayurveda.com

Rediscover health and confidence with EliteAyurveda. Together, we can overcome HS and its challenges.

References

Click here for references

González-López MA. Hidradenitis suppurativa. Med Clin (Barc). 2024 Feb 23;162(4):182-189. [PubMed]2.

Stancic BH, Boer J, Dolenc-Voljč M, Jemec GBE. The Role of Intra-Follicular Shear Forces in Hidradenitis Suppurativa. Skin Pharmacol Physiol. 2023;36(6):302-303. [PubMed]3.

Mintoff D, Pace NP. Differences in hidradenitis suppurativa patterns of cutaneous involvement between sexes: Insights from a cross-sectional study. Hum Immunol. 2024 Mar;85(2):110764. [PubMed]4.

Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells. 2021 Aug 15;10(8) [PMC free article] [PubMed]5.

Singh S, Desai K, Gillern S. Management of Pilonidal Disease and Hidradenitis Suppurativa. Surg Clin North Am. 2024 Jun;104(3):503-515. [PubMed]6.

Seivright J, Collier E, Grogan T, Shih T, Hogeling M, Shi VY, Hsiao JL. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022 Jun;33(4):2391-2393. [PMC free article] [PubMed]7.

Kirby J, Kim K, Zivkovic M, Wang S, Garg V, Danavar A, Li C, Chen N, Garg A. Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach. Front Med Technol. 2024;6:1200400. [PMC free article] [PubMed]8.

Yousef H, Miao JH, Alhajj M, Badri T. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 24, 2023. Histology, Skin Appendages. [PubMed]9.

Woodruff CM, Charlie AM, Leslie KS. Hidradenitis Suppurativa: A Guide for the Practicing Physician. Mayo Clin Proc. 2015 Dec;90(12):1679-93. [PubMed]10.

Balić A, Marinović B, Bukvić Mokos Z. The genetic aspects of hidradenitis suppurativa. Clin Dermatol. 2023 Sep-Oct;41(5):551-563. [PubMed]11.

Brandão LAC, Tricarico PM, Gratton R, Agrelli A, Zupin L, Abou-Saleh H, Moura R, Crovella S. Multiomics Integration in Skin Diseases with Alterations in Notch Signaling Pathway: PlatOMICs Phase 1 Deployment. Int J Mol Sci. 2021 Feb 03;22(4) [PMC free article] [PubMed]12.

Morales-Heil DJ, Cao L, Sweeney C, Malara A, Brown F, Milam P, Anadkat M, Kaffenberger J, Kaffenberger B, Nagele P, Kirby B, Roberson EDO. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023 Apr 13;4(2):100187. [PMC free article] [PubMed]13.

Tricarico PM, Gratton R, Dos Santos-Silva CA, de Moura RR, Ura B, Sommella E, Campiglia P, Del Vecchio C, Moltrasio C, Berti I, D’Adamo AP, Elsherbini AMA, Staudenmaier L, Chersi K, Boniotto M, Krismer B, Schittek B, Crovella S. A rare loss-of-function genetic mutation suggest a role of dermcidin deficiency in hidradenitis suppurativa pathogenesis. Front Immunol. 2022;13:1060547. [PMC free article] [PubMed]14.

Sun Q, Broadaway KA, Edmiston SN, Fajgenbaum K, Miller-Fleming T, Westerkam LL, Melendez-Gonzalez M, Bui H, Blum FR, Levitt B, Lin L, Hao H, Harris KM, Liu Z, Thomas NE, Cox NJ, Li Y, Mohlke KL, Sayed CJ. Genetic Variants Associated With Hidradenitis Suppurativa. JAMA Dermatol. 2023 Sep 01;159(9):930-938. [PMC free article] [PubMed]15.

Chu YL, Yu S. Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment. Biomedicines. 2024 Feb 01;12(2) [PMC free article] [PubMed]16.

Boer J, Jemec GBE. Mechanical forces and Hidradenitis Suppurativa. Exp Dermatol. 2021 Feb;30(2):212-215. [PubMed]17.

Zouboulis VA, Zouboulis KC, Zouboulis CC. Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing-A Molecular Meta-Analysis. Pharmaceutics. 2021 Dec 26;14(1) [PMC free article] [PubMed]18.

Ralser DJ, Basmanav FB, Tafazzoli A, Wititsuwannakul J, Delker S, Danda S, Thiele H, Wolf S, Busch M, Pulimood SA, Altmüller J, Nürnberg P, Lacombe D, Hillen U, Wenzel J, Frank J, Odermatt B, Betz RC. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa. J Clin Invest. 2017 Apr 03;127(4):1485-1490. [PMC free article] [PubMed]19.

Bukvić Mokos Z, Miše J, Balić A, Marinović B. Understanding the Relationship Between Smoking and Hidradenitis Suppurativa. Acta Dermatovenerol Croat. 2020 Jul;28(1):9-13. [PubMed]20.

Vossen ARJV, van Straalen KR, Swolfs EFH, van den Bosch JF, Ardon CB, van der Zee HH. Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis Suppurativa. Dermatology. 2021;237(3):383-385. [PubMed]21.

Nowak-Liduk A, Kitala D, Ochała-Gierek G, Łabuś W, Bergler-Czop B, Pietrauszka K, Niemiec P, Szyluk K, Gierek M. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments. Life (Basel). 2023 Sep 11;13(9) [PMC free article] [PubMed]22.

Chu CB, Yang CC, Tsai SJ. Hidradenitis suppurativa: Disease pathophysiology and sex hormones. Chin J Physiol. 2021 Nov-Dec;64(6):257-265. [PubMed]23.

Kisule A, Kak V, Alamelumangapuram C, Robinson C. Drug-Induced Hidradenitis Suppurativa: A Case Report. Cureus. 2023 Nov;15(11):e49637. [PMC free article] [PubMed]24.

Jfri A, Nassim D, O’Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis. JAMA Dermatol. 2021 Aug 01;157(8):924-931. [PMC free article] [PubMed]25.

Sinikumpu SP, Jokelainen J, Huilaja L. Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects. Acta Derm Venereol. 2024 Jan 10;104:adv14732. [PMC free article] [PubMed]26.

Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):7-16. [PubMed]27.

Greif C, Gibson RS, Kimball AB, Holcomb ZE, Porter ML. Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis. Int J Womens Dermatol. 2024 Mar;10(1):e129. [PMC free article] [PubMed]28.

van Straalen KR, Prens EP, Gudjonsson JE. Insights into hidradenitis suppurativa. J Allergy Clin Immunol. 2022 Apr;149(4):1150-1161. [PubMed]

Related-

Know more About Ayurveda Treatment for Hidradenitis Suppurativa.

GET IN TOUCH

Schedule a Visit

Contact us